FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214891418> ?p ?o ?g. }

• W4214891418 endingPage "489" @default.
• W4214891418 startingPage "476" @default.
• W4214891418 abstract "// Laura Moracci 1 , 2 , Francesca Sensi 1 , 3 , Andrea Biccari 1 , 2 , Sara Crotti 1 , 2 , Elisa Gaio 4 , Federico Benetti 4 , Pietro Traldi 1 , Salvatore Pucciarelli 1 , 2 and Marco Agostini 1 , 2 1 Nano-Inspired Biomedicine Lab, Fondazione Istituto di Ricerca Pediatrica Citt&#x00E0; della Speranza, Padova, Italy 2 General Surgical Clinic 3, Department of Surgical, Oncological and Gastroentrological Sciences, University of Padua, Padova, Italy 3 Department of Molecular Sciences and Nanosystems, Ca&#x2019; Foscari University of Venice, Mestre, Venice, Italy 4 ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy Correspondence to: Laura Moracci, email: laura-moracci@libero.it Marco Agostini, email: m.agostini@unipd.it Keywords: HT29; 5-fluorouracil; epigallocatechin-3-gallate; molecular complexes; gastrointestinal model Received: December 17, 2021     Accepted: February 17, 2022     Published: March 03, 2022 Copyright: © 2022 Moracci et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Recently an enhancement of the sensitivity of colorectal cancer (CRC) cells by 5-fluorouracil (5FU) due to the concurrent treatment with epigallocatechin-3-gallate (EGCG) has been found. In the present paper, to investigate on this aspect, adenocarcinoma cells HT29 were treated with 5FU, EGCG and an equimolar mixture of 5FU and EGCG ([5FU+EGCG]) and cell viability was determined. While 5FU exhibits a clear activity, EGCG alone does not express any activity. However by treating the cells with [5FU+EGCG] a strong effect of EGCG is evidenced: the sensitivity of HT29 cells to 5FU was increased by 12-fold. A simulation of the behavior of [5FU+EGCG] in different compartments of the gastrointestinal digestion model was also performed. 5FU and EGCG solubilized into a mixture of digestive fluids analyzed by mass spectrometry did not lead to signals of 5FU, EGCG and the related complex, while by diluting the solution they become detectable. On the contrary, when 5FU and EGCG are submitted to the step-by-step digestion model procedure, the analysis did not show the presence of 5FU, EGCG and [5FU+EGCG]. This behaviour could be ascribed to the instability of these compounds due to the too severe digestion conditions and/or to the complexity of the matrix which could lead in ESI conditions to the suppression of the signals of the analytes of interest." @default.
• W4214891418 created "2022-03-05" @default.
• W4214891418 creator A5001559084 @default.
• W4214891418 creator A5009891845 @default.
• W4214891418 creator A5016539648 @default.
• W4214891418 creator A5053030044 @default.
• W4214891418 creator A5055252814 @default.
• W4214891418 creator A5069850293 @default.
• W4214891418 creator A5074882867 @default.
• W4214891418 creator A5079854576 @default.
• W4214891418 creator A5090916040 @default.
• W4214891418 date "2022-03-03" @default.
• W4214891418 modified "2023-09-26" @default.
• W4214891418 title "An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid" @default.
• W4214891418 cites W1480219105 @default.
• W4214891418 cites W1808332509 @default.
• W4214891418 cites W1913701520 @default.
• W4214891418 cites W1914622032 @default.
• W4214891418 cites W1926018805 @default.
• W4214891418 cites W1967628954 @default.
• W4214891418 cites W1967833615 @default.
• W4214891418 cites W1967852813 @default.
• W4214891418 cites W1968242936 @default.
• W4214891418 cites W1978042751 @default.
• W4214891418 cites W1979756055 @default.
• W4214891418 cites W1984328540 @default.
• W4214891418 cites W2001493491 @default.
• W4214891418 cites W2008149578 @default.
• W4214891418 cites W2011388108 @default.
• W4214891418 cites W2018445772 @default.
• W4214891418 cites W2033346155 @default.
• W4214891418 cites W2033625132 @default.
• W4214891418 cites W2037870681 @default.
• W4214891418 cites W2051499457 @default.
• W4214891418 cites W2053471840 @default.
• W4214891418 cites W2061546695 @default.
• W4214891418 cites W2065442503 @default.
• W4214891418 cites W2068255220 @default.
• W4214891418 cites W2072647036 @default.
• W4214891418 cites W2085405112 @default.
• W4214891418 cites W2087784139 @default.
• W4214891418 cites W2088320437 @default.
• W4214891418 cites W2101750928 @default.
• W4214891418 cites W2104743116 @default.
• W4214891418 cites W2122169298 @default.
• W4214891418 cites W2128447158 @default.
• W4214891418 cites W2132209554 @default.
• W4214891418 cites W2136865018 @default.
• W4214891418 cites W2143638292 @default.
• W4214891418 cites W2162313061 @default.
• W4214891418 cites W2289315746 @default.
• W4214891418 cites W2479397168 @default.
• W4214891418 cites W2668032479 @default.
• W4214891418 cites W2731780586 @default.
• W4214891418 cites W2753000927 @default.
• W4214891418 cites W2889646458 @default.
• W4214891418 cites W2899364308 @default.
• W4214891418 cites W2912950397 @default.
• W4214891418 cites W2980178579 @default.
• W4214891418 cites W2982389988 @default.
• W4214891418 cites W3000718351 @default.
• W4214891418 cites W3004687495 @default.
• W4214891418 cites W3005923115 @default.
• W4214891418 cites W3012441117 @default.
• W4214891418 cites W3102203587 @default.
• W4214891418 cites W4253733495 @default.
• W4214891418 cites W639788823 @default.
• W4214891418 doi "https://doi.org/10.18632/oncotarget.28207" @default.
• W4214891418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35251495" @default.
• W4214891418 hasPublicationYear "2022" @default.
• W4214891418 type Work @default.
• W4214891418 citedByCount "3" @default.
• W4214891418 countsByYear W42148914182023 @default.
• W4214891418 crossrefType "journal-article" @default.
• W4214891418 hasAuthorship W4214891418A5001559084 @default.
• W4214891418 hasAuthorship W4214891418A5009891845 @default.
• W4214891418 hasAuthorship W4214891418A5016539648 @default.
• W4214891418 hasAuthorship W4214891418A5053030044 @default.
• W4214891418 hasAuthorship W4214891418A5055252814 @default.
• W4214891418 hasAuthorship W4214891418A5069850293 @default.
• W4214891418 hasAuthorship W4214891418A5074882867 @default.
• W4214891418 hasAuthorship W4214891418A5079854576 @default.
• W4214891418 hasAuthorship W4214891418A5090916040 @default.
• W4214891418 hasBestOaLocation W42148914181 @default.
• W4214891418 hasConcept C121608353 @default.
• W4214891418 hasConcept C126322002 @default.
• W4214891418 hasConcept C185592680 @default.
• W4214891418 hasConcept C190283241 @default.
• W4214891418 hasConcept C2777192995 @default.
• W4214891418 hasConcept C2778004101 @default.
• W4214891418 hasConcept C2780456651 @default.
• W4214891418 hasConcept C502942594 @default.
• W4214891418 hasConcept C55493867 @default.
• W4214891418 hasConcept C70899900 @default.
• W4214891418 hasConcept C71924100 @default.
• W4214891418 hasConceptScore W4214891418C121608353 @default.
• W4214891418 hasConceptScore W4214891418C126322002 @default.
• W4214891418 hasConceptScore W4214891418C185592680 @default.

• next